Beauty Farm Medical and Health Industry Inc. disclosed a repurchase of 20,000 ordinary shares on 18 May 2026 through on-market transactions on the Hong Kong Stock Exchange.

The shares were bought at prices ranging from HK$18.92 to HK$19.65, for a total consideration of HK$0.39 million and a volume-weighted average price of HK$19.53 per share.

Following the transaction: • Issued shares (excluding treasury shares) fell to 249.47 million, a reduction of 0.008%. • Treasury shares increased to 2.12 million, while total issued shares remained unchanged at 251.59 million.

The buyback forms part of the mandate approved on 27 June 2025, which authorises repurchases of up to 23.58 million shares. Cumulative buybacks under this mandate now stand at 2.12 million shares, representing 0.90% of the company’s issued share count on the mandate date (235.80 million).

Under Hong Kong listing rules, Beauty Farm is restricted from issuing new shares or selling treasury shares until 17 June 2026.